Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹8.2 LAdmitted-Finance | L1 | Admitted-Finance | |
| 2 | L2₹16.4 L+₹8.2 L (100.4%)Admitted-Finance OFFICE NO 207 2ND FLOOR EAST END PLAZA EAST END PLAZA VASUNDHARA ENCLAVE NEW DELHI EAST DELHI DELHI 110096 | EAST DELHI | DELHI | 110096 | L2 | Admitted-Finance | |
| 3 | L3₹31.0 L+₹22.8 L (277.9%)Admitted-Finance | L3 | Admitted-Finance | |
| 4 | L4₹31.9 L+₹23.7 L (289.0%)Admitted-Finance | L4 | Admitted-Finance | |
| 5 | L5₹48.6 L+₹40.4 L (492.9%)Admitted-Finance RIO RANGRAT OLD AIR FIELD ROAD BUDAM KASHMIR PIN 190007 J K | BUDGAM | JAMMU AND KASHMIR | 190007 | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Sanjay Stores L1 | M/S JAI GANESH PHARMACEUTICALS L2 | Navyug Enterprises L3 | NEW LIFE MEDICOS L4 | Gagan Associates L5 | M R ASSOCIATES L6 | Eastern Medical and Surgical Corporation L7 | SMPL Life Sciences Pvt. Ltd. L8 | SUMIT PHARMACEUTICALS PVT LTD L9 | D.N. Associates L10 | ALBINO LIFESCIENCES PVT. LTD L11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00PVMS No and Drugs | ||||||||||||||
| 1.01 | 013194 Albumin bound Paclitaxel 100 mg inj | 330 | VIAL | - | - | - | - | - | - | - | - | - | - | - |
| 1.02 | 012067 Bevacizumab 100 mg/4ml vial, Inj | 420 | VIAL | - | - | - | - | - | - | - | - | - | - | - |
| 1.03 | 013903 Cap Crizotinib 250 mg | 720 | No | - | - | - | - | - | - | - | - | - | - | - |
| 1.04 | NIV/01 Eribulin 1mg Inj | 72 | VIAL | - | - | - | - | - | - | - | - | - | - | - |
| 1.05 | 013911 Fulvestrant 250 mg Inj | 45 | VIAL | - | - | - | - | - | - | - | - | - | - | - |
| 1.06 | 013907 Inj Fosaprepitant 150mg | 750 | VIAL | - | - | - | - | - | - | - | - | - | - | - |
| 1.07 | 011715 Inj Goserelin 10.8 mg | 90 | PFS | - | - | - | - | - | - | - | - | - | - | - |
| 1.08 | NIV/01 Nanosomal Docetaxel(Lipid suspension)80 mg vial | 120 | VIAL | - | - | - | - | - | - | - | - | - | - | - |
| 1.09 | NIV/01 Nivolumab 100 mg Inj | 60 | No | - | - | - | - | - | - | - | - | - | - | - |
Tender Value
₹3.0 Cr
EMD Value
₹8.9 L
Closing Date
12 May 2020, 5:00 pmClosed
Commandant, Command Hospital (CC), Lucknow
The Commandant, Command Hospital, Central Command, Lucknow
As per RFP
2020_ARMY_341509_1
MS(PC)/13/IFA-03/Onco Drugs/2020-21
Open Tender
Miscellaneous Goods
Buy
30 days
Command Hospital (CC)
Please refer RFP
2 documents required · 2 mandatory
₹0
₹8.9 L
Yes
16 Jul 2020
29 Apr 2020
13 May 2020
29 Apr 2020
12 May 2020
29 Apr 2020
29 Apr 2020 - 12 May 2020
PVMS No and Drugs
013194 Albumin bound Paclitaxel 100 mg inj
012067 Bevacizumab 100 mg/4ml vial, Inj
013903 Cap Crizotinib 250 mg
NIV/01 Eribulin 1mg Inj
013911 Fulvestrant 250 mg Inj
013907 Inj Fosaprepitant 150mg
011715 Inj Goserelin 10.8 mg
NIV/01 Nanosomal Docetaxel(Lipid suspension)80 mg vial
NIV/01 Nivolumab 100 mg Inj
NIV/01 Nivolumab 40 mg Inj
013904 Regorafenib 40 mg Tab
010891 Sunitinib 50 mg Tab
010824Transtzumab 440 mg Inj
NIV/01 Ribocyclib 200 mg Tab
M/S JAI GANESH PHARMACEUTICALS
Navyug Enterprises
NEW LIFE MEDICOS
Gagan Associates
M R ASSOCIATES
Eastern Medical and Surgical Corporation
SMPL Life Sciences Pvt. Ltd.
SUMIT PHARMACEUTICALS PVT LTD
D.N. Associates
ALBINO LIFESCIENCES PVT. LTD
ALBINO LIFESCIENCES PVT. LTD
M/S JAI GANESH PHARMACEUTICALS
SUMIT PHARMACEUTICALS PVT LTD
Eastern Medical and Surgical Corporation
D.N. Associates
stage.html
html • 0.05 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.11 MB
BOQ_381654.xls
BOQ • 0.94 MB
RFPifa03.pdf
Tender Documents • 0.37 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .